HEALTHSCIENCE DAILY
The Ozempic and Wegovy mistake sending thousands to poison control
Poison control calls involving semaglutide (Ozempic and Wegovy) increased significantly after the drug's approval for weight management. Researchers attribute the rise to accidental dosing errors rather than intentional misuse, suggesting education on proper weekly dosing and gradual dose increases could prevent many incidents.
Mentioned
Related Signal
Adjacent reporting
- Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
- Accidental GLP-1 Overdose: Signs, Symptoms and Safe Dosing Rules
- Patients taking weight-loss drugs often make 5 critical mistakes, doctor warns
- Weight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concerns
- Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
- Kratom poisonings soar in US as experts blame synthetic versions and caution against bans